{"id":"https://openalex.org/W7212258237","doi":"https://doi.org/10.64898/2026.09.06.749721","title":"Generative Language Modeling for Antibody CDR Grafting and Alignment-driven De Novo Design","display_name":"Generative Language Modeling for Antibody CDR Grafting and Alignment-driven De Novo Design","publication_year":2026,"publication_date":"2026-09-10","ids":{"openalex":"https://openalex.org/W7212258237","doi":"https://doi.org/10.64898/2026.09.06.749721"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.06.749721","doi":"https://doi.org/10.64898/2026.09.06.749721","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.06.749721","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/10/2026.09.06.749721.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/10/2026.09.06.749721.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049926501","display_name":"Ferran Gonzalez Hernandez","orcid":"https://orcid.org/0000-0001-7184-7557","observed_orcids":["https://orcid.org/0000-0001-7184-7557"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Ferran Gonzalez Hernandez","raw_affiliation_strings":["AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-7184-7557","affiliations":[{"raw_affiliation_string":"AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030281702","display_name":"Oliver M. Turnbull","orcid":"https://orcid.org/0000-0002-0239-1207","observed_orcids":["https://orcid.org/0000-0002-0239-1207"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Oliver M Turnbull","raw_affiliation_strings":["Department of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0239-1207","affiliations":[{"raw_affiliation_string":"Department of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151361708","display_name":"Maliha Sultana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maliha Sultana","raw_affiliation_strings":["AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032687308","display_name":"Lorena Rold\u00e1n-Mart\u00edn","orcid":"https://orcid.org/0000-0002-6902-8285","observed_orcids":["https://orcid.org/0000-0002-6902-8285"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lorena Rold\u00e1n-Mart\u00edn","raw_affiliation_strings":["AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-6902-8285","affiliations":[{"raw_affiliation_string":"AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079615871","display_name":"Rohan Kumar","orcid":"https://orcid.org/0000-0003-4027-5028","observed_orcids":["https://orcid.org/0000-0003-4027-5028"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rohan J Kumar","raw_affiliation_strings":["AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058474860","display_name":"Tom Diethe","orcid":"https://orcid.org/0000-0002-0776-5407","observed_orcids":["https://orcid.org/0000-0002-0776-5407"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tom Diethe","raw_affiliation_strings":["AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0776-5407","affiliations":[{"raw_affiliation_string":"AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001968144","display_name":"Rebecca Croasdale-Wood","orcid":"https://orcid.org/0009-0003-4710-8414","observed_orcids":["https://orcid.org/0009-0003-4710-8414"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rebecca Croasdale-Wood","raw_affiliation_strings":["Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":"https://orcid.org/0009-0003-4710-8414","affiliations":[{"raw_affiliation_string":"Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015572211","display_name":"Charlotte Mary Deane","orcid":"https://orcid.org/0000-0003-1388-2252","observed_orcids":["https://orcid.org/0000-0003-1388-2252"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Deane","raw_affiliation_strings":["Department of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-1388-2252","affiliations":[{"raw_affiliation_string":"Department of Statistics, University of Oxford, Oxford, OX1 3LB, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061934775","display_name":"Dino Ogli\u0107","orcid":"https://orcid.org/0000-0002-4728-9644","observed_orcids":["https://orcid.org/0000-0002-4728-9644"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dino Oglic","raw_affiliation_strings":["AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-4728-9644","affiliations":[{"raw_affiliation_string":"AI for Discovery Science, Enterprise AI Unit, AstraZeneca, Cambridge, CB2 0AA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5049926501"],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6753000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6753000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.15230000019073486,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10044","display_name":"Protein Structure and Dynamics","score":0.07509999722242355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/de-novo-antibody-design","display_name":"de novo antibody design","score":0.8579999804496765},{"id":"https://openalex.org/keywords/generative-language-models","display_name":"generative language models","score":0.7609999775886536},{"id":"https://openalex.org/keywords/llama","display_name":"llamas","score":0.5460000038146973},{"id":"https://openalex.org/keywords/prompt-conditioning","display_name":"prompt conditioning","score":0.4000000059604645},{"id":"https://openalex.org/keywords/nanobodies","display_name":"nanobodies","score":0.7229999899864197},{"id":"https://openalex.org/keywords/developability","display_name":"developability","score":0.6850000023841858},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.8309999704360962},{"id":"https://openalex.org/keywords/closed-loop-design","display_name":"closed-loop design","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.6656000018119812},{"id":"https://openalex.org/C159877910","wikidata":"https://www.wikidata.org/wiki/Q2202883","display_name":"Autoregressive model","level":2,"score":0.5859000086784363},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5845999717712402},{"id":"https://openalex.org/C43521106","wikidata":"https://www.wikidata.org/wiki/Q2165493","display_name":"Pipeline (software)","level":2,"score":0.5411999821662903},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.49889999628067017},{"id":"https://openalex.org/C2778112365","wikidata":"https://www.wikidata.org/wiki/Q3511065","display_name":"Sequence (biology)","level":2,"score":0.4887000024318695},{"id":"https://openalex.org/C113843644","wikidata":"https://www.wikidata.org/wiki/Q901882","display_name":"Interface (matter)","level":4,"score":0.44600000977516174},{"id":"https://openalex.org/C137293760","wikidata":"https://www.wikidata.org/wiki/Q3621696","display_name":"Language model","level":2,"score":0.40869998931884766},{"id":"https://openalex.org/C167966045","wikidata":"https://www.wikidata.org/wiki/Q5532625","display_name":"Generative model","level":3,"score":0.40139999985694885},{"id":"https://openalex.org/C140779682","wikidata":"https://www.wikidata.org/wiki/Q210868","display_name":"Sampling (signal processing)","level":3,"score":0.3725999891757965},{"id":"https://openalex.org/C70437156","wikidata":"https://www.wikidata.org/wiki/Q7228652","display_name":"Pooling","level":2,"score":0.3646000027656555},{"id":"https://openalex.org/C108944566","wikidata":"https://www.wikidata.org/wiki/Q1524510","display_name":"Panning (audio)","level":4,"score":0.36390000581741333},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.3458000123500824},{"id":"https://openalex.org/C62354387","wikidata":"https://www.wikidata.org/wiki/Q875399","display_name":"Boundary (topology)","level":2,"score":0.3273000121116638},{"id":"https://openalex.org/C39890363","wikidata":"https://www.wikidata.org/wiki/Q36108","display_name":"Generative grammar","level":2,"score":0.31299999356269836},{"id":"https://openalex.org/C177148314","wikidata":"https://www.wikidata.org/wiki/Q170084","display_name":"Generalization","level":2,"score":0.3089999854564667},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.30329999327659607},{"id":"https://openalex.org/C11413529","wikidata":"https://www.wikidata.org/wiki/Q8366","display_name":"Algorithm","level":1,"score":0.29580000042915344},{"id":"https://openalex.org/C28719098","wikidata":"https://www.wikidata.org/wiki/Q44946","display_name":"Point (geometry)","level":2,"score":0.2955000102519989},{"id":"https://openalex.org/C195324797","wikidata":"https://www.wikidata.org/wiki/Q33742","display_name":"Natural language","level":2,"score":0.29350000619888306},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.2825999855995178},{"id":"https://openalex.org/C2777735758","wikidata":"https://www.wikidata.org/wiki/Q817765","display_name":"Path (computing)","level":2,"score":0.2809999883174896},{"id":"https://openalex.org/C2779843651","wikidata":"https://www.wikidata.org/wiki/Q7390335","display_name":"SIGNAL (programming language)","level":2,"score":0.26420000195503235},{"id":"https://openalex.org/C2779664074","wikidata":"https://www.wikidata.org/wiki/Q3518405","display_name":"Terminal (telecommunication)","level":2,"score":0.26339998841285706},{"id":"https://openalex.org/C66882249","wikidata":"https://www.wikidata.org/wiki/Q169336","display_name":"Homogeneous","level":2,"score":0.2621999979019165},{"id":"https://openalex.org/C45484198","wikidata":"https://www.wikidata.org/wiki/Q827246","display_name":"Sequence alignment","level":4,"score":0.2551000118255615}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.06.749721","doi":"https://doi.org/10.64898/2026.09.06.749721","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.06.749721","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/10/2026.09.06.749721.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.06.749721","doi":"https://doi.org/10.64898/2026.09.06.749721","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.06.749721","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/10/2026.09.06.749721.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7212258237.pdf","grobid_xml":"https://content.openalex.org/works/W7212258237.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2736601468","https://openalex.org/W4322718191","https://openalex.org/W4399198515","https://openalex.org/W4405562589","https://openalex.org/W4416329770","https://openalex.org/W4416790848","https://openalex.org/W7203439560"],"related_works":["https://openalex.org/W4416795858","https://openalex.org/W4385568338","https://openalex.org/W3205745483","https://openalex.org/W7202204485","https://openalex.org/W4388020856","https://openalex.org/W4413043632","https://openalex.org/W4309048124","https://openalex.org/W7204237064","https://openalex.org/W6966860666","https://openalex.org/W4404200234"],"abstract_inverted_index":{"Antibodies":[0],"recognise":[1],"their":[2],"targets":[3],"through":[4],"hypervariable":[5],"complementarity-determining":[6],"regions":[7],"(CDRs),":[8],"which":[9,31,169],"are":[10,226],"interleaved":[11],"with":[12,127,183,196],"conserved":[13],"frameworks":[14,68],"in":[15,177],"sequence":[16],"space,":[17],"making":[18,82],"de":[19,217],"novo":[20,218],"CDR":[21,37,43,83,113,152],"design":[22],"an":[23],"infilling":[24],"problem.":[25],"Autoregressive":[26],"models":[27,64,117,223],"generate":[28,74],"residues":[29],"left-to-right,":[30],"precludes":[32],"full":[33],"framework":[34,41],"context":[35],"during":[36],"generation":[38],"and":[39,42,73,98,105,118,129,162,221],"conflates":[40],"likelihoods,":[44],"leaving":[45],"no":[46,171],"natural":[47],"prompt\u2013response":[48,133],"interface":[49,180,203],"for":[50,89,141,224],"feedback":[51],"to":[52,150,207,214],"steer":[53,151],"generation.":[54,153],"We":[55],"present":[56],"GenCDR,":[57],"a":[58,70,79,85,186,212],"family":[59,93],"of":[60,157,185],"LLaMa-based":[61],"autoregressive":[62,116],"language":[63],"that":[65,167],"read":[66],"all":[67,75],"as":[69,78],"conditioning":[71],"prompt":[72],"CDRs":[76,123],"jointly":[77],"variable-length":[80],"response,":[81],"likelihoods":[84,125],"clean,":[86],"separable":[87],"target":[88],"reward":[90,139],"attribution.":[91],"The":[92,132,201],"comprises":[94],"IgGenCDR,":[95],"p-IgGenCDR":[96],",":[97,100],"NanoGenCDR":[99],"trained":[101],"on":[102],"unpaired,":[103],"paired,":[104],"nanobody":[106],"chains,":[107],"respectively.":[108],"GenCDR":[109,225],"achieves":[110],"the":[111,193],"highest":[112],"recovery":[114],"among":[115],"produces":[119],"natural,":[120,198],"diverse,":[121],"human-like":[122],"whose":[124],"correlate":[126],"fitness":[128],"developability":[130,146,163],"assays.":[131],"boundary":[134],"also":[135],"enables":[136],"principled":[137],"alignment:":[138],"signals":[140],"binding":[142],"affinity,":[143],"expression,":[144],"or":[145],"can":[147,175,204],"be":[148,205],"composed":[149],"Over":[154],"four":[155],"rounds":[156],"alignment":[158],"against":[159],"antibody\u2013antigen":[160],"co-folding":[161],"objectives,":[164],"we":[165],"find":[166],"NanoGenCDR,":[168],"uses":[170],"explicit":[172],"antigen":[173],"encoding,":[174],"reach":[176],"silico":[178],"structural":[179],"metrics":[181],"competitive":[182],"those":[184],"structure-conditioned":[187],"diffusion":[188],"pipeline":[189],"at":[190,228],"roughly":[191],"half":[192],"sampling":[194],"budget,":[195],"more":[197],"developable":[199],"designs.":[200],"same":[202],"extended":[206],"integrate":[208],"experimental":[209],"feedback,":[210],"opening":[211],"path":[213],"closed-loop":[215],"antibody":[216],"design.":[219],"Code":[220],"pre-trained":[222],"available":[227],"https://github.com/AstraZeneca/GenCDR":[229],".":[230]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-12T00:00:00"}